It’s difficult to evaluate the metabolism of large and poorly permeabilized drug compounds in the conventional in vitro liver models due to their size, structure, and limited membrane permeability. Our new blog post explores how these factors impact drug development and how permeabilized hepatocytes offer a novel solution to overcome these challenges. Read the new blog post:?https://lnkd.in/edK3NpXP #hepatocytes #ADMET?
